These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 15580679)

  • 21. Spironolactone in patients with heart failure.
    Larkin RJ; Atlas SA; Donohue TJ
    N Engl J Med; 2000 Jan; 342(2):132-3; author reply 133-4. PubMed ID: 10636751
    [No Abstract]   [Full Text] [Related]  

  • 22. Worsening of motor symptoms and gynecomastia during spironolactone treatment in a patient with Parkinson's disease and congestive heart failure.
    Teive HA; Munhoz RP; Werneck LC
    Mov Disord; 2007 Aug; 22(11):1678-9. PubMed ID: 17534964
    [No Abstract]   [Full Text] [Related]  

  • 23. Spironolactone in patients with heart failure.
    Vanpee D; Swine C
    N Engl J Med; 2000 Jan; 342(2):133; author reply 133-4. PubMed ID: 10636753
    [No Abstract]   [Full Text] [Related]  

  • 24. [Hyperkalemia and impaired renal function in patients taking spironolactone for congestive heart failure. A retrospective analysis of 125 consecutive cases].
    Svensson M; Gustafsson F; Galatius S; Hildebrandt PR; Atar D
    Ugeskr Laeger; 2004 Sep; 166(37):3201-3. PubMed ID: 15384373
    [No Abstract]   [Full Text] [Related]  

  • 25. Aldosterone blockade in patients with heart failure and a reduced left ventricular ejection fraction.
    Pitt B
    Eur Heart J; 2009 Feb; 30(4):387-8. PubMed ID: 19190013
    [No Abstract]   [Full Text] [Related]  

  • 26. [Old man with bosom].
    Winter M
    MMW Fortschr Med; 2006 Jun; 148(26):61. PubMed ID: 16875387
    [No Abstract]   [Full Text] [Related]  

  • 27. The role of aldosterone blockade in end-stage renal disease.
    Pitt B; Saran R
    Cardiology; 2009; 114(1):30-1. PubMed ID: 19342856
    [No Abstract]   [Full Text] [Related]  

  • 28. Adding spironolactone to conventional antihypertensives reduces albuminuria in patients with diabetic nephropathy.
    Epstein M
    Nat Clin Pract Nephrol; 2006 Jun; 2(6):310-1. PubMed ID: 16932450
    [No Abstract]   [Full Text] [Related]  

  • 29. [Spironolactone and potassium].
    Kjeldsen K
    Ugeskr Laeger; 2004 Nov; 166(48):4392; author reply 4392-3. PubMed ID: 15587639
    [No Abstract]   [Full Text] [Related]  

  • 30. Drug safety in patients with heart failure.
    Juurlink DN; Hansten PD
    Arch Intern Med; 2005 Jan; 165(1):118. PubMed ID: 15642888
    [No Abstract]   [Full Text] [Related]  

  • 31. [Spironolactone as a cardio-protective drug].
    Yoshimura M
    Nihon Rinsho; 2007 May; 65 Suppl 5():107-9. PubMed ID: 17569309
    [No Abstract]   [Full Text] [Related]  

  • 32. [Urea and spironolactone therapy].
    Schwarzbach W; Bunzl W
    Munch Med Wochenschr; 1973 Jan; 115(3):76-80. PubMed ID: 4739290
    [No Abstract]   [Full Text] [Related]  

  • 33. [Late drug-induced hyperkalemia in a patient with congestive heart failure].
    Konopa J; Bułło B; Rutkowski B
    Przegl Lek; 2005; 62(7):732-3. PubMed ID: 16463712
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum concentration of potassium in chronic heart failure patients administered spironolactone plus furosemide and either enalapril maleate, losartan potassium or candesartan cilexetil.
    Saito M; Takada M; Hirooka K; Isobe F; Yasumura Y
    J Clin Pharm Ther; 2005 Dec; 30(6):603-10. PubMed ID: 16336294
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tolerability of spironolactone as adjunctive treatment for heart failure in patients over 75 years of age.
    Dinsdale C; Wani M; Steward J; O'Mahony MS
    Age Ageing; 2005 Jul; 34(4):395-8. PubMed ID: 15955761
    [No Abstract]   [Full Text] [Related]  

  • 36. Hyperkalaemia and impaired renal function in patients taking spironolactone for congestive heart failure: retrospective study.
    Svensson M; Gustafsson F; Galatius S; Hildebrandt PR; Atar D
    BMJ; 2003 Nov; 327(7424):1141-2. PubMed ID: 14615339
    [No Abstract]   [Full Text] [Related]  

  • 37. [No effect of spironolactone on bulimia nervosa symptoms].
    von Wietersheim J; Müller-Bock V; Rauh S; Danner B; Chrenko K; Bühler G
    Psychother Psychosom Med Psychol; 2008 Dec; 58(12):470-4. PubMed ID: 18666040
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Spironolactone and congestive heart-failure.
    Georges B; Beguin C; Jadoul M
    Lancet; 2000 Apr; 355(9212):1369-70. PubMed ID: 10776778
    [No Abstract]   [Full Text] [Related]  

  • 39. Hyperkalaemia: again.
    Gross P; Pistrosch F
    Nephrol Dial Transplant; 2004 Sep; 19(9):2163-6. PubMed ID: 15299094
    [No Abstract]   [Full Text] [Related]  

  • 40. Spironolactone-potion or poison?
    Drug Ther Bull; 2017 Feb; 55(2):13. PubMed ID: 28153847
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.